CDXS Codexis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDXS

Price (delayed)

$2.385

Market cap

$216.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.36

Enterprise value

$251.08M

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 74
Relative Valuation: Rel. Valuation: 18
Relative Profitability: Rel. Profitability: 40
Highlights
Codexis's gross profit has surged by 95% YoY and by 14% QoQ
The EPS has surged by 63% year-on-year and by 28% since the previous quarter
The debt has grown by 23% YoY
The equity has declined by 14% since the previous quarter and by 13% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: https://www.cedexis.com/
Peers: BCPC MRK PFE DD

Key stats

What are the main financial stats of CDXS

CDXS stock price

How has the Codexis stock price performed over time
Intraday
0.63%
1 week
-3.83%
1 month
-4.22%
1 year
1.06%
YTD
46.32%
QTD
46.32%

Financial performance

How have Codexis's revenue and profit performed over time
Revenue
$78.09M
Gross profit
$69.42M
Operating income
-$29.3M
Net income
-$31.99M
Gross margin
88.9%
Net margin
-41%
Codexis's gross profit has surged by 95% YoY and by 14% QoQ
The net margin has soared by 73% YoY and by 34% from the previous quarter
The operating margin has surged by 72% year-on-year and by 37% since the previous quarter
CDXS's revenue has surged by 57% year-on-year and by 11% since the previous quarter

Price vs fundamentals

How does CDXS's price correlate with its fundamentals

Growth

What is Codexis's growth rate over time

Valuation

What is Codexis stock price valuation
P/E
N/A
P/B
5.01
P/S
2.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.22
The EPS has surged by 63% year-on-year and by 28% since the previous quarter
CDXS's price to book (P/B) is 28% higher than its last 4 quarters average of 3.9 and 11% higher than its 5-year quarterly average of 4.5
The equity has declined by 14% since the previous quarter and by 13% year-on-year
CDXS's revenue has surged by 57% year-on-year and by 11% since the previous quarter
The price to sales (P/S) is 52% lower than the 5-year quarterly average of 5.7 and 5% lower than the last 4 quarters average of 2.9

Efficiency

How efficient is Codexis business performance
The return on sales has surged by 73% year-on-year and by 38% since the previous quarter
The company's return on invested capital has surged by 61% YoY and by 32% QoQ
Codexis's return on assets has surged by 56% YoY and by 27% QoQ
Codexis's return on equity has increased by 43% YoY and by 25% QoQ

Dividends

What is CDXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDXS.

Financial health

How did Codexis financials performed over time
CDXS's total assets is 50% greater than its total liabilities
CDXS's quick ratio is up by 48% year-on-year and by 41% since the previous quarter
Codexis's current ratio has increased by 44% YoY and by 40% QoQ
The debt is 69% more than the equity
The company's debt to equity rose by 41% YoY and by 17% QoQ
The debt has grown by 23% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.